Join
Live feed
·
INSIDERFilingvia Quantisnow
Editas Medicine Inc. logo

EVP, CHIEF FINANCIAL OFFICER Lucera Erick sold $7,030 worth of shares (4,109 units at $1.71), decreasing direct ownership by 4% to 112,720 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EDIT (Editas Medicine Inc.) and more on Quantisnow.